Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IV, Multi-Center, Open-Label, Safety and Effectiveness Study of Extended-Release Carbamazepine in the Treatment of Mania in Children and Adolescents Aged 10-17 Years With Acute Manic or Mixed Bipolar I Disorder.

NCT00350857 is registered in ClinicalTrials.gov with Validus Pharmaceuticals as lead sponsor.

NCT NCT00350857
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00350857 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IV, Multi-Center, Open-Label, Safety and Effectiveness Study of Extended-Release Carbamazepine in the Treatment of Mania in Children and Adolescents Aged 10-17 Years With Acute Manic or Mixed Bipolar I Disorder.
Lead sponsor
Validus Pharmaceuticals
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2006
Completion date
October 31, 2007
Enrollment
161 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar i disorder